Skip to content
Sanbra Industries

Services06

Specialty Technology

Niche technologies with industrial substance: soil stabilization, early-stage biotech, technology sourcing.

0606Sectors: Infrastructure & Rail / Food & Beverage / Mining & Minerals

Beyond the core industrial clusters, we carry a small set of specialty technologies chosen for substance rather than breadth. In infrastructure, we offer advanced soil stabilization for road construction: treating the ground that is already there into a load-bearing layer instead of excavating it and importing material.

In biotechnology, we are building an early commercial position in high-value microalgae-derived bioactive ingredients for pharmaceutical, nutraceutical, and cosmetic applications. We present this exactly as what it is, an emerging line at an early stage. Where a client needs a technology we do not carry, we source and coordinate licensing for it.

  • Advanced soil stabilization

    In-place stabilization of soils for road and infrastructure construction.

  • Road construction consulting

    Feasibility and design support for stabilization-based road projects.

  • Microalgae-derived bioactives

    High-value bioactive ingredients for pharma, nutraceutical, and cosmetic applications, at an early commercial stage.

  • Technology sourcing & licensing

    Sourcing, evaluation, and licensing coordination for specialist industrial technologies.

Soil stabilization: the engineering case

Conventional road construction excavates weak ground and replaces it with imported layers of gravel and crushed stone. Stabilization takes the opposite route: the existing soil is treated in place and compacted into the load-bearing layer itself. Less excavation, less material haulage, shorter construction sequences, and a road bed engineered from what the site already provides. We advise on where the method fits, and support projects from feasibility through design.

Biotech ingredients, stated plainly

Microalgae are a concentrated source of bioactive compounds that pharmaceutical, nutraceutical, and cosmetic formulators pay a premium for. Our position in this field is early-stage and we say so. We are developing the line deliberately, and we will publish claims only as they become verifiable. Inquiries from formulators and distributors interested in the pipeline are welcome now.

NEXT STEP

Ask about a specific application

A road project that could skip the gravel imports, or interest in the bioactives pipeline. Both start with a short technical conversation.